파마리서치

214450KOSDAQ

63.1 / 100

Reference Date: 2026-09-08

Financial Score26.5 / 40

News Sentiment19.6 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Parmaresearch is a biopharmaceutical company specializing in regenerative medicine, leveraging PDRN/PN technology to develop and sell pharmaceuticals, medical devices, and cosmetics. Established in 2013 with a GMP-certified factory in Gangneung and expanded with a second plant in 2019, the company's key products include Regenix, Rejuran, and Conjuuran. It plans to expand into Asian, European, and North American markets, while its subsidiary also operates a botulinum toxin business.

Number of Employees

526people

Average Salary

68.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

25.21Industry Average 15.001.5Point

1.7x industry avg (risky)

PBR

5.40Industry Average 1.200.0Point

4.5x industry avg (risky)

ROE

26.02Industry Average 8.007.0Point

3.3x industry avg (excellent)

Debt Ratio

28.95Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~202510.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲43.7% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲53.4% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 20.6% (improving, 3yr)

Detailed News Sentiment

36 totalPositive 31Neutral 4Negative 1Average Sentiment Score 78.3

Positive
약국으로 향하는 K뷰티…‘성분·효능’ 중시 소비자 공략
파마리서치의 주요 제품이 약국 채널을 통해 확장되며, 젊은 세대와 외국인 관광객 증가로 인해 성장 기회가 확대되고 있다.
Neutral
4% 넘게 뛴 코스피, '칠천피' 눈앞…코스닥은 1%대 상승
전반적인 코스피 상승에도 불구하고 파마리서치의 직접적인 영향은 언급되지 않았습니다.
Positive
[단독] 손지훈 대표 "이젠 리쥬란 다음 타자 준비…토털 미용의료 기....
파마리서치의 손지훈 대표가 장기 전략을 발표하며 새로운 에너지 기반 미용기기 개발 계획을 공개해 긍정적인 시장 반응을 이끌어냈다.

Detailed Momentum

52-week position3.0Point

52w lower range (25%)

Current 376,500Won52-week high 675,00052-week low 276,000

1-month return3.0Point

1m -0.53% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업설명회(IR)개최2026-09-01
Neutral반기보고서 (2026.06)2026-08-14